Table 2.
Indicators for healthcare utilization
| |
CLL group |
Control group |
Attributable to CLL |
|
|
|
||
|---|---|---|---|---|---|---|---|---|
| Mean | STD | Mean | STD | Lower limit (2.5%) | Mean | Upper limit (97.5%) | p-Value | |
| Sick leave days (paid and unpaid days) |
7.6 |
(35.5) |
3.1 |
(19.6) |
3.6 |
4.4 |
5.2 |
<.001 (Logit) <.001 (NB)a |
| Physician contacts |
14.7 |
(7.5) |
9.4 |
(6.6) |
5.1 |
5.3 |
5.4 |
<.001b |
| Inpatient stays |
0.95 |
(2.10) |
0.36 |
(0.96) |
0.54 |
0.59 |
0.63 |
0.007b |
| Average length of stay (if hospitalized) |
9.4 |
|
8.8 |
|
|
0.5 |
|
|
| Prescriptions |
18.2 |
(19.3) |
12.8 |
(14.4) |
5.0 |
5.4 |
5.9 |
<.001a |
| Average prescription cost | 148.2 | 44.5 | 103.8 | |||||
CLL chronic lymphocytic leukemia, STD Standard deviation.
a) Zero-inflated negative binomial specified model; b) Negative binominal specified model.